Notice of Extraordinary General Meeting and Proxy Form
Released
Released
Announcement PDF
FLYNN GOLD LIMITED
ABN 82 644 122 216
Notice of Extraordinary General
Meeting
Explanatory Statement and Proxy Form
Date of Meeting:
Wednesday, 16 April 2025
Time of Meeting:
10:00 AM (AEST)
The meeting will be held virtually via a webinar conferencing facility. If you are a shareholder who wishes to attend
and participate in the virtual meeting, please register in advance as per the instructions outlined in this Notice of
Meeting. Shareholders are strongly encouraged to lodge their completed proxy forms in accordance with the
instructions in this Notice of Meeting.
The Notice of Meeting has been given to those entitled to receive by use of one or more technologies. The Notice
of Meeting is also available on the Australian Securities Exchange Announcement platform and on the Company’s
website https://flynngold.com.au/.
This Notice of Extraordinary General Meeting and Explanatory Statement should be read in its entirety.
If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant,
solicitor, or other professional advisor without delay.
FLYNN GOLD LIMITED
ABN 82 644 122 216
Registered office: Level 4, 100 Albert Road, South Melbourne, VIC 3205
Notice is hereby given that the Extraordinary General Meeting of Shareholders of Flynn Gold Limited (“Flynn
Gold” or the “Company”) will be held virtually at 10.00am (AEST) on Wednesday, 16 April 2025 (“General
Meeting”, “EGM” or “Meeting”).
Shareholders are encouraged to submit their proxies as early as possible, and in any event, prior to the cut-off date
for proxy voting as set out in the Notice. To lodge your proxy, please follow the directions on your personalised proxy
form.
Shareholders attending the EGM virtually will be able to ask questions and the Company has made provision for
Shareholders who register their attendance before the start of the meeting to also cast their votes on the proposed
resolutions at the EGM.
The virtual meeting can be attended using the following details:
When:
Topic:
Wednesday, 16 April 2025 at 10.00am (AEST)
Flynn Gold Limited Extraordinary General Meeting
Register in advance for the virtual meeting:
https://vistra.zoom.us/webinar/register/WN_bUCWge7aQsGYtQosZ_sjVA
After registering, you will receive a confirmation email containing information about joining the meeting. As noted
previously, the Company strongly recommends its shareholders lodge a directed proxy as soon as possible in
advance of the meeting even if they are planning to attend the meeting online. The Company will conduct a poll on
each resolution presented at the meeting. The Company will accept questions during the meeting either by submitting
a question through the Q&A box located on screen or by raising the hand function also located on screen at which
point the Company will allow your question verbally.
The Company is happy to accept and answer questions submitted prior to the meeting by email to
mathew.watkins@vistra.com. The Company will address relevant questions during the meeting or by written
response after the Meeting (subject to the discretion of the Company not to respond to unreasonable and/or offensive
questions).
Any shareholders who wish to attend the EGM online should therefore monitor the Company’s website and its ASX
announcements for any updates about the EGM. If it becomes necessary or appropriate to make alternative
arrangements for the holding or conducting of the meeting, the Company will make further information available
through the ASX website at asx.com.au (ASX: FG1) and on its website at https://flynngold.com.au/.
AGENDA
The Explanatory Statement and proxy form which accompany and form part of this Notice, include defined terms
and describe in more detail the matters to be considered. Please consider this Notice, the Explanatory Statement
and the proxy form in their entirety. Defined terms used in this Notice have the meanings given to them in the
Glossary at the end of this Notice.
ORDINARY BUSINESS
Resolution 1: Ratify issue of 59,904,800 Shares issued as part of Tranche 1 Placement
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders approve, ratify and confirm the
allotment and issue of 59,904,800 fully paid ordinary shares in the Company on 7 March 2025 at an issue price of
$0.02 (2 cents) per Share in relation to Tranche 1 of the Placement, to professional, sophisticated and other exempt
investors as described in the Explanatory Statement.”
Resolution 2: Approval to issue 41,500,000 Options as part of the Placement
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, Shareholders approve, the allotment and
issue of 41,500,000 free attaching Unlisted Options, in the Company, to professional, sophisticated and other
exempt investors who participated in the Placement, as described in the Explanatory Statement accompanying the
Notice of Meeting."
Resolution 3: Approval to issue 23,095,200 Shares as part of Tranche 2 placement
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, Shareholders approve, the allotment and
issue of 23,095,200 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share , in the Company in
relation to Tranche 2 of the Placement, to professional, sophisticated and other exempt investors, as described in
the Explanatory Statement accompanying the Notice of Meeting."
Resolution 4: Approval to issue 2,500,000 shares and 1,250,000 Options as part of Tranche 2 placement to
Director Clive Duncan (and/or his nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve, the allotment and
issue of 2,500,000 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share and 1,250,000 free
attaching Unlisted Options, in the Company to Mr Clive Duncan (and/or his nominee(s)), Non-Executive Chair of
the Company, on the terms and conditions set out in the Explanatory Statement accompanying the Notice of
Meeting."
Resolution 5: Approval to issue 1,250,000 Shares and 625,000 Options as part of Tranche 2 placement to
Director Samuel Garrett (and/or his nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve, the allotment and
issue of 1,250,000 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share and 625,000 free
attaching Unlisted Options, in the Company to Mr Samuel Garrett (and/or his nominee(s)), Technical Director of the
Company, on the terms and conditions set out in the Explanatory Statement accompanying the Notice of Meeting."
Resolution 6: Approval to issue 750,000 Shares and 375,000 Options as part of Tranche 2 placement to
Director John Forwood (and/or his nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve, the allotment and
issue of 750,000 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share and 375,000 free attaching
Unlisted Options, in the Company, to Mr John Forwood (and/or his nominee(s)), Non-Executive Director of the
Company, on the terms and conditions set out in the Explanatory Statement accompanying the Notice of Meeting."
Resolution 7: Approval to issue 2,500,000 Shares and 1,250,000 Options as part of Tranche 2 placement to
Director Neil Marston (and/or his nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve, the allotment and
issue of 2,500,000 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share and 1,250,000 free
attaching Unlisted Options, in the Company to Mr Neil Marston (and/or his nominee(s)), Managing Director of the
Company, on the terms and conditions set out in the Explanatory Statement accompanying the Notice of Meeting."
Resolution 8: Approval to issue 40,000,000 Shares and 20,000,000 Options as part of Tranche 2 placement
to Colin Bourke, a substantial 10% plus shareholder (and/or his nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve, the allotment and
issue of 40,000,000 fully paid ordinary shares at an issue price of $0.02 (2 cents) per Share and 20,000,000 free
attaching Unlisted Options, in the Company to Mr Colin Bourke (and/or his nominee(s)), who is a related party by
virtue of holding greater than 30% of the Company’s issued capital in the last 6 months on the terms and conditions
set out in the Explanatory Statement accompanying the Notice of Meeting."
Resolution 9: Approval to issue of 500,000 Options to the Lead Manager in connection with the Placement
(or their nominee(s))
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval be given to grant up to 500,000
Unlisted Options in the Company to the Lead Manager of the Share Placement announced on 27 February 2025,
Bell Potter Securities Ltd, (or their nominee(s)), on the terms and conditions set out in the Explanatory Statement
accompanying the Notice of Meeting.”
By the order of the Board
Mathew Watkins
Company Secretary
13 March 2025
Notes
a) Entire Notice: The details of the resolutions contained in the Explanatory Statement accompanying this Notice of Meeting should be read
together with, and form part of, this Notice of Meeting.
b) Record Date: The Company has determined that for the purposes of the Extraordinary General Meeting, shares will be taken to be held by
the persons who are registered as holding the shares at 7pm on the date 48 hours before the date of the Extraordinary General Meeting. Only
those persons will be entitled to vote at the Extraordinary General Meeting and transfers registered after that time will be disregarded in
determining entitlements to attend and vote at the Extraordinary General Meeting.
c) Proxies
a.
Votes at the Extraordinary General Meeting may be given personally or by proxy, attorney or representative.
b.
Each shareholder has a right to appoint one or two proxies.
c.
A proxy need not be a shareholder of the Company.
d.
If a shareholder is a company, it must execute under its common seal or otherwise in accordance with its constitution or the Corporations
Act.
e.
Where a shareholder is entitled to cast two or more votes, the shareholder may appoint two proxies and may specify the proportion of
number of votes each proxy is appointed to exercise.
f.
If a shareholder appoints two proxies, and the appointment does not specify the proportion or number of the shareholder’s votes, each
proxy may exercise half of the votes. If a shareholder appoints two proxies, neither proxy may vote on a show of hands.
g.
A proxy must be signed by the shareholder or his or her attorney who has not received any notice of revocation of the authority.
h.
To be effective, Proxy Forms must be received by the Company’s share registry Computershare Investor Services Pty Ltd no later than
48 hours before the commencement of the Extraordinary General Meeting, i.e. no later than 10:00am AEST on Monday, 14 April 2025.
Any proxy received after that time will not be valid for the scheduled meeting.
i.
By post to Computershare Investor Services Pty Limited, GPO Box 242, Melbourne Victoria 3001
ii.
In person to Computershare Investor Services Pty Limited, ‘Yarra Falls’, 452 Johnston Street, Abbotsford Victoria 3067
iii.
By fax to 1800 783 447 (within Australia) or +61 9473 2555 (outside Australia)
iv.
Online by going to www.investorvote.com.au or by scanning the QR code found on the enclosed proxy form with your mobile
device
v.
For Intermediary Online subscribers only (custodians) please visit www.intermediaryonline.com to submit your voting
intentions
d) Corporate Representative
Any corporate shareholder who has appointed a person to act as its corporate representative at the Extraordinary General Meeting should
provide that person with a certificate or letter executed in accordance with the Corporations Act authorising him or her to act as that company’s
representative. The authority may be sent to the Company and/or registry in advance of the Extraordinary General Meeting or handed in at
the Extraordinary General Meeting when registering as a corporate representative.
e) How the Chair will vote Undirected Proxies
Subject to the restrictions set out in Note 6 below, the Chair of the Extraordinary General Meeting will vote undirected proxies in favour of all
the proposed resolutions.
f)
Voting Exclusion Statement:
Resolutions 1 to 3 and 9
The Company will disregard any votes cast in favour of these resolutions by or on behalf of any persons who participated or are expected to
participate in the securities issue or who will obtain a material benefit as a result of the issue of securities (except a benefit solely by reason
of being a holder of ordinary securities in the entity) or any associates of that person or those persons.
However, this does not apply to a vote cast in favour of these resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy or
attorney to vote on the resolution in that way; or
(b) the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given
to the chair to vote on the resolution as the chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
i.
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate
of a person excluded from voting, on the resolution; and
ii.
the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
Resolutions 4 through to 8
The Company will disregard any votes cast in favour of Resolutions 4 through to 8 by or on behalf of:
Mr Clive Duncan, Mr John Forwood, Mr Samuel Garrett, Mr Neil Marston and Mr Colin Bourke (in respect of each of their standalone
resolutions only) or any person(s) who will obtain a material benefit as a result of the proposed issue (except a benefit solely by reason
of being a holder of ordinary securities in the entity), or
an associate of person referred to in the preceding paragraph.
However, this does not apply to a vote cast in favour of a resolution by:
(a)
(b)
(c)
a person as a proxy or attorney for a person who is entitled to vote on the Resolutions, in accordance with directions given to the proxy
or attorney to vote on the resolution in that way; or
the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolutions, in accordance with a direction given
to the Chair to vote on the Resolution(s) as the Chair decides; or
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
a. the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a
person excluded from voting, on the Resolutions; and
b. the holder votes on the Resolutions in accordance with directions given by the beneficiary to the holder to vote in that way.
Furthermore, a vote must not be cast as proxy on any Resolutions 4 through to 8 by a member of the Key Management Personnel (as defined
by the Corporations Act) or a closely related party of Key Management Personnel.
However, a person described above (a “Restricted Voter”) may cast a vote on any Resolutions 4 through to 8, as a proxy if:
(a) The Restricted Voter is appointed as a proxy by writing that specifies the way the proxy is to vote on the Resolution(s); or
(b) The Chairman is the Restricted Voter and the written appointment of the Chairman as proxy does not specify the way the proxy is to vote
on the Resolution(s) or expressly authorises the Chairman to exercise the proxy even though the Resolution(s) is or are connected with
the remuneration of a member of the Key Management Personnel.
If you appoint the Chairman as your proxy and you do not direct the Chairman how to vote, you will be expressly authorising the Chairman to
exercise the proxy even if the relevant resolution is connected directly or indirectly with the remuneration of a member of the Key Management
Personnel for the Company.
g) Enquiries
Shareholders are invited to contact the Company Secretary, Mathew Watkins on +61(3) 9692 7222 if they have any queries in respect of the
matters set out in this Notice.
EXPLANATORY STATEMENT
Purpose of Information
This Explanatory Statement (“Statement”) accompanies and forms part of the Company’s Notice of Extraordinary
General Meeting (“Notice”) for the Extraordinary General Meeting (“Meeting”) will be held virtually via a webinar
conferencing facility at 10.00am (AEST) on Wednesday, 16 April 2025.
The Notice incorporates, and should be read together, with this Statement.
Background to Resolutions
On 27 February 2025, the Company announced that it had raised $2.6 million via a Placement to professional,
sophisticated and other exempt investors. The Placement will result in the issue of 130,000,000 fully paid ordinary
shares (Shares) at $0.02 (2 cents) per share and 65,000,000 free attaching unlisted options (Options), exercisable
at $0.04 (4 cents), expiring 36 months from the date of issue, on the basis of one Option for every two Shares issued.
The issue price represented a discount of 23% to the Company’s 15 day VWAP as at 24 February 2025 of $0.026.
The Placement would be undertaken in two tranches. Tranche 1 resulted in 59,904,800 Shares being issued within
the Company’s existing placement capacity under Listing Rule 7.1 and 7.1A on Thursday, 7 March 2025.
Tranche 2 is subject to shareholder approval and if approved will result in 70,095,200 Shares and 65,000,000 Options
being issued. Each of the Directors have provided firm commitments to participate in the Placement, subject to
shareholder approval, which approval is being sought under Resolutions 4-7. Included in the Tranche 2 issue is also
40,000,000 Shares and 20,000,00 Options to be issued to the Colin Bourke (or his nominee(s)), a substantial
shareholder with greater than 30% interest in the Company within the past 6 months, subject to shareholder approval,
of which approval is being sought under Resolutions 8.
Bell Potter Securities Ltd was sole lead manager and bookrunner to the Placement. The fees of the lead manager
were a Management and Selling Fee of 6% of the proceeds raised. In addition, 500,000 options carrying the same
terms as the Options to be issued to Placement participants, to be issued to the lead Manager subject to shareholder
approval.
The two tranche Placement and associated resolutions are summarised below:
Resolution 1 to ratify the issue of 59,904,800 shares under the Placement Tranche 1;
Resolution 2 to approve the issue of 41,500,000 Options as part of the Placement;
Resolution 3 to approve the issue of 23,095,200 shares under the Placement Tranche 2;
Resolutions 4-7 to seek approval for the Directors to participate in the Placement on the same terms as the
institutional and professional investors;
Resolution 8 to seek approval for Colin Bourke to participate in the Placement on the same terms as the
professional and sophisticated investors; and
Resolution 9 to seek approval for the issue of 500,00 Options to the lead manager in connection with the
Placement.
Resolution 1: Ratify issue of 59,904,800 Shares issues as part of Tranche 1 Placement
Background
As noted above, the Company is seeking shareholder approval pursuant to ASX Listing Rule 7.4 to ratify the issue
of 59,904,800 Shares on 7 March 2025 at an issue price of $0.02 (2 cents) per Share on the terms as announced on
27 February 2025, to professional, sophisticated and other exempt investors under the Placement.
The Shares were issued without shareholder approval from the Company’s 15% placement capacity pursuant to ASX
Listing Rule 7.1 and 10% placement capacity pursuant to ASX Lising Rule 7.1A..
ASX Listing Rules
ASX Listing Rules 7.1 allow the Company to issue new securities up to 15% of the existing capital of the Company
in any 12-month period without the prior approval of Shareholders, unless one of the exceptions in ASX Listing Rule
7.2 applies.
ASX Listing Rule 7.1A provides that a Company may seek shareholder approval at its annual general meeting to
issue additional quoted securities up to 10% of its issued capital, provided that it is an eligible entity (Eligible Entity).
An Eligible Entity is one that, as at the date of the relevant annual general meeting –
a) it must have a market capitalisation of $300 million or less.
b) it must not be included in the S&P/ASX 300 Index.
At the time the approval was obtained (the Company’s last Annual General Meeting 20 November 2024), the
Company was an Eligible Entity.
Under ASX Listing Rule 7.4 an issue of securities will be treated as having been made with the approval of
shareholders for the purposes of ASX Listing Rules 7.1 and 7.1A if the issue did not breach ASX Listing Rules 7.1
and 7.1A at the time and shareholders subsequently approve it. The Company now seeks Shareholder ratification of
the issue pursuant to ASX Listing Rule 7.4 in order to retain as much flexibility as possible to issue additional equity
securities into the future without having to obtain shareholder approval for such issues under Listing Rule 7.1.
If this Resolution is approved, the prior issue of 59,904,800 Shares may be treated by the Company as having been
made with Shareholder approval under ASX Listing Rule 7.1. The Company will therefore have the flexibility, if
required, to issue additional equity securities without the 59,904,800 Shares counting towards the 25% threshold for
the purposes of ASX Listing Rules 7.1 and 7.1A.
If this Resolution is not approved, the prior issue of 59,904,800 Shares will not be treated by the Company as having
been made with Shareholder approval under ASX Listing Rules 7.1. The Company will therefore have the 59,904,800
Shares, as counting towards the 25% threshold for the purposes of ASX Listing Rules 7.1 and 7.1A.
ASX Listing Rule 7.5 requires that the following information be provided to Shareholders for the purpose of obtaining
Shareholder approval pursuant to ASX Listing Rule 7.4:
a) The Tranche 1 Shares were issued to new and existing shareholders identified as professional, sophisticated
and other exempt investors, identified by the book build conducted by the lead managers. There were no
participants in the Placement that were investors required to be disclosed under ASX Guidance Note 21,
such as related parties of the entity, member of the Company’s key management personnel, substantial
shareholders of the Company, advisors of the Company and they have not been issued with more than 1%
of the current issued capital;
b) the number and class of securities issued were 59,904,800 fully paid ordinary shares in the Company issued
on 7 March 2025;
c) the Tranche 1 Shares were issued at a price of $0.02 (2 cents) per Share; and
d) the purpose of the issue was to raise funds to further drilling at the Golden Ridge project, the Henty SilverLead project, advance other exploration opportunities and general working capital.
Board Recommendation
The Board recommends that shareholders vote in favour of Resolution 2.
The Chair of the Meeting intends to vote undirected proxies in favour of this Resolution.
Voting Exclusions
See Note 6 for voting exclusions on this resolution.
Resolution 2: Approval to issue 41,500,000 Options as part of the Placement
Background
The Company is seeking Shareholder approval pursuant to ASX Listing Rule 7.1, to issue 41,500,000 Options to
professional, sophisticated and other exempt investors who participated in the Placement,on the terms as announced
on 27 February 2025.
ASX Listing Rules
ASX Listing Rule 7.1 provides that a company must not, without shareholder approval, issue or agree to issue more
securities during any 12 month period than that amount which represents 15% of the number of fully paid ordinary
securities on issue at the commencement of that 12 month period. As the issue of 41,500,000 Options, without
shareholder approval, exceed that 15% limit, the Company proposes Resolution 3 to seek shareholder approval
under Listing Rule 7.1.
If this Resolution is passed, the Company will issue the 41,500,000 Options without using any of its placement
capacity under Listing Rule 7.1, retain the flexibility to make future issues of equity securities up to the 15% limit.
If this Resolution is not passed, the Company would not be able to proceed with the issue of up 41,500,000 Options
with shareholder approval however may consider issuing the securities out of its placement capacity under ASX
Listing Rule 7.1
ASX Listing Rule 7.3 requires that the following information be provided to Shareholders for the purpose of obtaining
Shareholder approval pursuant to ASX Listing Rule 7.1:
a) The Options will be issued to professional, sophisticated and other exempt investors who participated in the
Placement;
b) the number and class of securities to be issued is 41,500,000 Options;
c) the date by which the Company will issue the securities will be no later than three (3) months after the date
of this Meeting (or such later date as may be approved by ASX). The Company however expects to issue
the shares on or around 30 April 2025;
d) the Options are to be issued to the investors under the Tranche 1 Placement, with an exercise price of 0.04
(4 cents), expiring 36 months from the date of issue. The material terms of Options are as set out in Annexure
A; and
e) the issue of Options will not raise any funds however, if any options are exercised in the future, the funds
raised will be used to advance projects or working capital at the time of any such exercise.
Board Recommendation
The Board recommends that shareholders vote in favour of Resolution 2.
The Chair of the Meeting intends to vote undirected proxies in favour of this Resolution.
Voting Exclusions
Refer to Note 6 for voting exclusions.
Resolution 3: Approval to issue 23,095,200 shares as part of Tranche 2 of Placement
Background
The Company is seeking Shareholder approval pursuant to ASX Listing Rule 7.1, to issue, 23,095,200 Shares in the
Company at $0.02 (2 cents) per share, as part of the Tranche 2 placement. on the terms as announced on 27
February 2025, to professional, sophisticated and other exempt investors under the Placement
A further 47,000,000 Shares and 23,500,000 Options, are to be issued to Directors and a Substantial Shareholder
on the same terms and approval for those issues is sought under resolutions 5 through to 8.
ASX Listing Rules
ASX Listing Rule 7.1 provides that a company must not, without shareholder approval, issue or agree to issue more
securities during any 12 month period than that amount which represents 15% of the number of fully paid ordinary
securities on issue at the commencement of that 12 month period. As the issue of 23,095,200 Shares, without
shareholder approval, exceed that 15% limit, the Company proposes Resolution 3 to seek shareholder approval
under Listing Rule 7.1.
If this Resolution is passed, the Company will issue the 23,095,200 Shares without using any of its placement
capacity under Listing Rule 7.1, retain the flexibility to make future issues of equity securities up to the 15% limit and
raise approximately $461,904 before issue costs. If this Resolution is not passed, the Company will not be able to
proceed with the issue of 23,095,200 Shares Options under the Placement with shareholder approval however may
consider issuing the securities out of its placement capacity under ASX Listing Rule 7.1.
ASX Listing Rule 7.3 requires that the following information be provided to Shareholders for the purpose of obtaining
Shareholder approval pursuant to ASX Listing Rule 7.1:
f)
The Shares will be issued to professional, sophisticated and other exempt investors who are not related
parties identified by the book build conducted by the lead manager;
g) the number and class of securities to be issued are 23,095,200 fully paid ordinary share in the Company;
h) the date by which the Company will issue the securities will be no later than three (3) months after the date
of this Meeting (or such later date as may be approved by ASX). The Company however expects to issue
the shares on or around 30 April 2025;
i) the issue price of the Shares will be $0.02 (2 cents);
j) the purpose of the issue is to raise fund to further drilling at the Golden Ridge project, the Henty Silver-Lead
project, advance other exploration opportunities and general working capital.
Board Recommendation
The Board recommends that shareholders vote in favour of Resolution 3.
The Chair of the Meeting intends to vote undirected proxies in favour of this Resolution.
Voting Exclusions
Refer to Note 6 for voting exclusions.
Resolution 4 through to 8: Approval
Share your feedback
Discover